Swarajya

Our View
HeadlinesMagazineVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief

Hydroxychloroquine-Azithromycin (HCQ-AZ)

Coronavirus: Hydroxychloroquine Administered Early Decreased Mortality Hazard Ratio By 66%, A New Study Finds  
Coronavirus: Hydroxychloroquine Administered Early Decreased Mortality Hazard Ratio By 66%, A New Study Finds  Swarajya StaffJul 3, 2020 08:00 PM +05:30 IST
Covid-19 Antivirals: Looking For A Signal Amidst The Noise
Covid-19 Antivirals: Looking For A Signal Amidst The NoiseV. NiranjanJun 14, 2020 12:25 PM +05:30 IST
WHO To Resume Hydroxychloroquine’s Coronavirus Trials After Study Based On Which It Was Stopped Turns Out To Be Dubious
WHO To Resume Hydroxychloroquine’s Coronavirus Trials After Study Based On Which It Was Stopped Turns Out To Be DubiousSwarajya StaffJun 4, 2020 07:07 AM +05:30 IST
 New ICMR Study: Sustained Intake Of HCQ Prophylaxis And Appropriate PPEs Lowers  Infection Risk For Healthcare Workers
New ICMR Study: Sustained Intake Of HCQ Prophylaxis And Appropriate PPEs Lowers Infection Risk For Healthcare WorkersSwarajya StaffJun 1, 2020 10:42 AM +05:30 IST
Explained: Should India Continue Testing Anti-Malarial Drug HCQ For Treating COVID-19 After WHO Moratorium?
Explained: Should India Continue Testing Anti-Malarial Drug HCQ For Treating COVID-19 After WHO Moratorium?Swarajya StaffMay 28, 2020 05:46 PM +05:30 IST
US Begins Clinical Trial Of Hydroxychloroquine, Azithromycin  
US Begins Clinical Trial Of Hydroxychloroquine, Azithromycin  IANSMay 15, 2020 11:13 AM +05:30 IST
A New Study Unveiled By Prominent French Virologist Claims  HCQ-AZ Combination Removed Novel Coronavirus  In 92 Per Cent Cases
A New Study Unveiled By Prominent French Virologist Claims HCQ-AZ Combination Removed Novel Coronavirus In 92 Per Cent CasesSwarajya StaffApr 11, 2020 01:12 PM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype